Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes

Jun Zhang*, D. Ware Branch, Mildred M. Ramirez, S. Katherine Laughon, Uma Reddy, Mathew Hoffman, Jennifer Bailit, Michelle Kominiarek, Zhen Chen, Judith U. Hibbard

*Corresponding author for this work

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

To examine the effects and safety of high-dose (compared with low-dose) oxytocin regimen for labor augmentation on perinatal outcomes. Data from the Consortium on Safe Labor were used. A total of 15,054 women from six hospitals were eligible for the analysis. Women were grouped based on their oxytocin starting dose and incremental dosing of 1, 2, and 4 milliunits/min. Duration of labor and a number of maternal and neonatal outcomes were compared among these three groups stratified by parity. Multivariable logistic regression and generalized linear mixed model were used to adjust for potential confounders. Oxytocin regimen did not affect the rate of cesarean delivery or other perinatal outcomes. Compared with 1 milliunit/min, the regimens starting with 2 milliunits/min and 4 milliunits/min reduced the duration of first stage by 0.8 hours (95% confidence interval 0.5-1.1) and 1.3 hours (1.0-1.7), respectively, in nulliparous women. No effect was observed on the second stage of labor. Similar patterns were observed in multiparous women. High-dose regimen was associated with a reduced risk of meconium stain, chorioamnionitis, and newborn fever in multiparous women. High-dose oxytocin regimen (starting dose at 4 milliunits/min and increment of 4 millliunits/min) is associated with a shorter duration of first-stage of labor for all parities without increasing the cesarean delivery rate or adversely affecting perinatal outcomes. II.

Original languageEnglish (US)
Pages (from-to)249-256
Number of pages8
JournalObstetrics and Gynecology
Volume118
Issue number2
DOIs
StatePublished - Jan 1 2011

Fingerprint

Oxytocin
Parity
Second Labor Stage
Chorioamnionitis
First Labor Stage
Meconium
Linear Models
Fever
Coloring Agents
Logistic Models
Mothers
Newborn Infant
Confidence Intervals
Safety

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Zhang, J., Branch, D. W., Ramirez, M. M., Laughon, S. K., Reddy, U., Hoffman, M., ... Hibbard, J. U. (2011). Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. Obstetrics and Gynecology, 118(2), 249-256. https://doi.org/10.1097/AOG.0b013e3182220192
Zhang, Jun ; Branch, D. Ware ; Ramirez, Mildred M. ; Laughon, S. Katherine ; Reddy, Uma ; Hoffman, Mathew ; Bailit, Jennifer ; Kominiarek, Michelle ; Chen, Zhen ; Hibbard, Judith U. / Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. In: Obstetrics and Gynecology. 2011 ; Vol. 118, No. 2. pp. 249-256.
@article{5621ddab3b9443fc84815f6e9f58afe6,
title = "Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes",
abstract = "To examine the effects and safety of high-dose (compared with low-dose) oxytocin regimen for labor augmentation on perinatal outcomes. Data from the Consortium on Safe Labor were used. A total of 15,054 women from six hospitals were eligible for the analysis. Women were grouped based on their oxytocin starting dose and incremental dosing of 1, 2, and 4 milliunits/min. Duration of labor and a number of maternal and neonatal outcomes were compared among these three groups stratified by parity. Multivariable logistic regression and generalized linear mixed model were used to adjust for potential confounders. Oxytocin regimen did not affect the rate of cesarean delivery or other perinatal outcomes. Compared with 1 milliunit/min, the regimens starting with 2 milliunits/min and 4 milliunits/min reduced the duration of first stage by 0.8 hours (95{\%} confidence interval 0.5-1.1) and 1.3 hours (1.0-1.7), respectively, in nulliparous women. No effect was observed on the second stage of labor. Similar patterns were observed in multiparous women. High-dose regimen was associated with a reduced risk of meconium stain, chorioamnionitis, and newborn fever in multiparous women. High-dose oxytocin regimen (starting dose at 4 milliunits/min and increment of 4 millliunits/min) is associated with a shorter duration of first-stage of labor for all parities without increasing the cesarean delivery rate or adversely affecting perinatal outcomes. II.",
author = "Jun Zhang and Branch, {D. Ware} and Ramirez, {Mildred M.} and Laughon, {S. Katherine} and Uma Reddy and Mathew Hoffman and Jennifer Bailit and Michelle Kominiarek and Zhen Chen and Hibbard, {Judith U.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1097/AOG.0b013e3182220192",
language = "English (US)",
volume = "118",
pages = "249--256",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Zhang, J, Branch, DW, Ramirez, MM, Laughon, SK, Reddy, U, Hoffman, M, Bailit, J, Kominiarek, M, Chen, Z & Hibbard, JU 2011, 'Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes', Obstetrics and Gynecology, vol. 118, no. 2, pp. 249-256. https://doi.org/10.1097/AOG.0b013e3182220192

Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. / Zhang, Jun; Branch, D. Ware; Ramirez, Mildred M.; Laughon, S. Katherine; Reddy, Uma; Hoffman, Mathew; Bailit, Jennifer; Kominiarek, Michelle; Chen, Zhen; Hibbard, Judith U.

In: Obstetrics and Gynecology, Vol. 118, No. 2, 01.01.2011, p. 249-256.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes

AU - Zhang, Jun

AU - Branch, D. Ware

AU - Ramirez, Mildred M.

AU - Laughon, S. Katherine

AU - Reddy, Uma

AU - Hoffman, Mathew

AU - Bailit, Jennifer

AU - Kominiarek, Michelle

AU - Chen, Zhen

AU - Hibbard, Judith U.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - To examine the effects and safety of high-dose (compared with low-dose) oxytocin regimen for labor augmentation on perinatal outcomes. Data from the Consortium on Safe Labor were used. A total of 15,054 women from six hospitals were eligible for the analysis. Women were grouped based on their oxytocin starting dose and incremental dosing of 1, 2, and 4 milliunits/min. Duration of labor and a number of maternal and neonatal outcomes were compared among these three groups stratified by parity. Multivariable logistic regression and generalized linear mixed model were used to adjust for potential confounders. Oxytocin regimen did not affect the rate of cesarean delivery or other perinatal outcomes. Compared with 1 milliunit/min, the regimens starting with 2 milliunits/min and 4 milliunits/min reduced the duration of first stage by 0.8 hours (95% confidence interval 0.5-1.1) and 1.3 hours (1.0-1.7), respectively, in nulliparous women. No effect was observed on the second stage of labor. Similar patterns were observed in multiparous women. High-dose regimen was associated with a reduced risk of meconium stain, chorioamnionitis, and newborn fever in multiparous women. High-dose oxytocin regimen (starting dose at 4 milliunits/min and increment of 4 millliunits/min) is associated with a shorter duration of first-stage of labor for all parities without increasing the cesarean delivery rate or adversely affecting perinatal outcomes. II.

AB - To examine the effects and safety of high-dose (compared with low-dose) oxytocin regimen for labor augmentation on perinatal outcomes. Data from the Consortium on Safe Labor were used. A total of 15,054 women from six hospitals were eligible for the analysis. Women were grouped based on their oxytocin starting dose and incremental dosing of 1, 2, and 4 milliunits/min. Duration of labor and a number of maternal and neonatal outcomes were compared among these three groups stratified by parity. Multivariable logistic regression and generalized linear mixed model were used to adjust for potential confounders. Oxytocin regimen did not affect the rate of cesarean delivery or other perinatal outcomes. Compared with 1 milliunit/min, the regimens starting with 2 milliunits/min and 4 milliunits/min reduced the duration of first stage by 0.8 hours (95% confidence interval 0.5-1.1) and 1.3 hours (1.0-1.7), respectively, in nulliparous women. No effect was observed on the second stage of labor. Similar patterns were observed in multiparous women. High-dose regimen was associated with a reduced risk of meconium stain, chorioamnionitis, and newborn fever in multiparous women. High-dose oxytocin regimen (starting dose at 4 milliunits/min and increment of 4 millliunits/min) is associated with a shorter duration of first-stage of labor for all parities without increasing the cesarean delivery rate or adversely affecting perinatal outcomes. II.

UR - http://www.scopus.com/inward/record.url?scp=79961088794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961088794&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3182220192

DO - 10.1097/AOG.0b013e3182220192

M3 - Article

C2 - 21775839

AN - SCOPUS:79961088794

VL - 118

SP - 249

EP - 256

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2

ER -

Zhang J, Branch DW, Ramirez MM, Laughon SK, Reddy U, Hoffman M et al. Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes. Obstetrics and Gynecology. 2011 Jan 1;118(2):249-256. https://doi.org/10.1097/AOG.0b013e3182220192